Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
复制标题
验证 Bmi1 作为小鼠肝细胞癌的治疗靶点
DOI:
10.3390/ijms151120004
复制
发表时间:
2014-11-03
影响因子:
5.6
通讯作者:
Xu C
中科院分区:
文献类型:
--
作者:
Qi S;Li B;Yang T;Liu Y;Cao S;He X;Zhang P;Li L;Xu C
Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of various cancers and governs the self-renewal of multiple types of stem cells. Our previous studies have revealed that Bmi1 acts as an oncogene in hepatic carcinogenesis in an INK4a/ARF locus independent manner. However, whether Bmi1 can be used as a potential target for hepatocellular carcinoma treatment has not been fully confirmed yet. Here, we show that perturbation of Bmi1 expression by using short hairpin RNA can inhibit the tumorigenicity and tumor growth of hepatocellular carcinoma cells both in vitro and in vivo. Importantly, Bmi1 knockdown can block the tumor growth, both in the initiating stages and the fast growing stages. Cellular biology analysis revealed that Bmi1 knockdown induces cell cycle arrest and apoptosis. Our findings verify Bmi1 as a qualified treatment target for hepatocellular carcinoma (HCC) and support Bmi1 targeting treatment with chemotherapeutic agents.
登录
查看更多内容
影响因子:
8
作者:
Hoenerhoff, M. J.;Chu, I.;Barkan, D.;Liu, Z-y;Datta, S.;Dimri, G. P.;Green, J. E.
通讯作者:
Green, J. E.
DOI:
10.1186/bcr2214
发表时间:
2008
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Pietersen AM;Horlings HM;Hauptmann M;Langerød A;Ajouaou A;Cornelissen-Steijger P;Wessels LF;Jonkers J;van de Vijver MJ;van Lohuizen M
通讯作者:
van Lohuizen M
影响因子:
3.7
作者:
Becker M;Korn C;Sienerth AR;Voswinckel R;Luetkenhaus K;Ceteci F;Rapp UR
通讯作者:
Rapp UR
影响因子:
11.2
作者:
Datta, Sonal;Hoenerhoff, Mark J.;Dimri, Goberdhan P.
通讯作者:
Dimri, Goberdhan P.
影响因子:
11.2
作者:
Chiba, Tetsuhiro;Miyagi, Satoru;Iwama, Atsushi
通讯作者:
Iwama, Atsushi